#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Leiomyosarcoma metastatic Parkinson's disease Fibrous dysplasia of bone Acute lymphocytic leukaemia Marginal zone lymphoma refractory Lymphatic malformation Fragile X syndrome IgA nephropathy Prodromal Alzheimer's disease Myelodysplastic syndrome Pulmonary alveolar haemorrhage Piriformis syndrome Deafness bilateral Familial hypertriglyceridaemia Andersen-Tawil syndrome More trials…

    Learn about Rare Diseases

    Atypical teratoid/rhabdoid tumour of CNS – Life with Disease Chronic granulomatous disease – Trials in Disease Mucous membrane pemphigoid – Diagnostics Hereditary angioedema – Diagnostics Atypical teratoid/rhabdoid tumour of CNS Ocular melanoma – Diagnostics Mucopolysaccharidosis I – Treatment Alternating hemiplegia of childhood – Life with Disease Nodal marginal zone B-cell lymphoma – Basic Information Angiosarcoma metastatic – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gedatolisib Metoprolol Tartrate Exl01 Treprostinil Palmitil Azd8421 Eprosartan Mesilate Av-Ec2023 Rly-4008 Nanatinostat Lenomorelin Levofloxacin Emtricitabine Alglucosidase Alfa Rasburicase BUMETANIDE Ivacaftor GSKVX000000044501 Cetrimide Entecavir Ficlatuzumab More therapies…

    Learn about Your Condition

    Mucopolysaccharidosis Vascular dementia B-cell lymphoma refractory Bone hypertrophy Osteomyelitis Mitochondrial myopathy Thrombolysis Respiratory tract infection Pulmonary vascular disorder Polymyositis Tooth loss Nicotine dependence Ventricular fibrillation Hyperoxaluria Indolent systemic mastocytosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Influenza

  • Study of mRNA-based seasonal influenza vaccine to evaluate immune response and safety in adults 18 years and older

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • GSKVX000000034794
    • GSKVX000000034798
    • GSKVX000000048110
    Belgium

  • Study of mRNA-based seasonal influenza vaccine combinations compared to standard influenza vaccines in adults aged 18 and older

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • GSKVX000000034794
    • GSKVX000000034798
    • GSKVX000000048110
    Belgium

  • Study on Influenza Immunity: Comparing Nasal FluMist and Injectable Vaxigriptetra Vaccines for Adults

    Not recruiting

    3 1 1
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • INFLUENZA VIRUS B/AUSTRIA/1359417/2021 – LIKE STRAIN (B/AUSTRIA/1359417/2021, MEDI 355292)
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    Denmark

  • Study on the Safety and Immune Response of aQIVc HD Vaccine Compared to a Drug Combination for Adults 50 Years and Older at Risk of Flu Complications

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • A/(H3N2)-LIKE VIRUS ANTIGEN
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • A/H1N1 INFLUENZA VACCINE
    Denmark Estonia Germany

  • A Study of OVX836 Influenza Vaccine Given as Booster or Primary Vaccination in Healthy Adults Who Previously Received OVX836, Influenza Vaccine, or Placebo

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • INFLUENZA A (H1N1/WSN/1933) NUCLEOPROTEIN FUSED TO C-TERMINAL FRAGMENTS OF TWO AVIAN C4BP ALFA CHAIN SEQUENCES
    Belgium

  • Study on the Best Time for Influenza Vaccine Administration in Adults Aged 60-85 Using Influenza Vaccine and Drug Combination

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 17F
    • Pneumococcal Polysaccharide Serotype 2
    • Pneumococcal Polysaccharide Serotype 20
    The Netherlands
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!